Modic vertebral endplate marrow changes
vigentePer-disc-level MRI phenotype of vertebral endplate-adjacent marrow signal: fibrovascular/edematous type 1, fatty type 2 and sclerotic type 3, including mixed patterns. It is a descriptive imaging classification, not proof of infection, a pain generator or a treatment indication.
As figuras e tabelas estão na fonte primária. Abrir a fonte. O RadCommons reescreve e cita, não reproduz figuras protegidas por direitos autorais.
Procedência e vigência
- Órgão emissor
- Modic et al. / ISSLS Degenerative Spinal Phenotypes Group
- Versão
- 1988 types 1-3; ISSLS reporting recommendations and evidence through 2026
- Ano
- 1988
- Família
- léxico
- Tipo de lógica
- flat
- Modalidade
- MRI
- Fonte primária
- Degenerative disk disease: assessment of changes in vertebral body marrow with MR imaging · doi:10.1148/radiology.166.1.3336678
- Última verificação
- 2026-07-24
- Última checagem
- 2026-08-12
Lógica de decisão
Forma estruturada (flat). Uma futura calculadora a lê; as categorias abaixo são a superfície legível.
Classify endplate-adjacent marrow per level from sequence-aware T1/T2 evidence, preserve mixed patterns and dangerous mimics, and never turn a Modic type into pain causality, infection exclusion or an autonomous treatment instruction.
Mostrar a lógica estruturada (JSON)
{
"categories": [
{
"outcome_code": "1",
"conventional_T1": "low_relative_to_normal_vertebral_marrow",
"conventional_non_fat_suppressed_T2": "high",
"tissue_correlate": "endplate_disruption_and_fissuring_with_fibrovascular_marrow_replacement_and_increased_water",
"shorthand": "fibrovascular_or_edematous_pattern"
},
{
"outcome_code": "2",
"conventional_T1": "high",
"conventional_non_fat_suppressed_T2": "isointense_to_slightly_high",
"tissue_correlate": "fatty_yellow_marrow_replacement",
"shorthand": "fatty_pattern"
},
{
"outcome_code": "3",
"conventional_T1": "low",
"conventional_non_fat_suppressed_T2": "low",
"tissue_correlate": "subchondral_bone_sclerosis",
"shorthand": "sclerotic_pattern"
}
],
"applicability": {
"intended_use": "Describe vertebral endplate-adjacent bone-marrow signal associated with a degenerative disc at each named spinal level.",
"original_population": "The original classification was developed in lumbar degenerative disc disease; application in the cervical or thoracic spine should retain the region and be labeled as extrapolation rather than silent original validation.",
"unit_of_analysis": "A disc/endplate level, with the cranial and caudal vertebral endplates, side, anterior-posterior distribution and extent retained rather than a single patient-level type.",
"required_sequences": [
"non_fat_suppressed_T1_weighted_MRI",
"non_fat_suppressed_T2_weighted_MRI_or_sequence_context_that_allows_equivalent_interpretation"
],
"outside_scope": [
"disc_degeneration_grade_use_Pfirrmann_separately",
"disc_herniation_or_annular_fissure",
"canal_or_foraminal_stenosis",
"proof_of_discitis_osteomyelitis",
"identification_of_a_pain_generator",
"treatment_selection"
]
},
"technical_and_reporting_gate": {
"reference": "Compare endplate-adjacent signal with normal vertebral marrow on the same examination and interpret it in the patient's age and marrow context.",
"sequence_dependency": "Field strength, echo time, fat suppression, spatial resolution and other acquisition parameters change conspicuity and apparent extent; record the sequences used when serially measuring or researching Modic change.",
"fat_suppression_trap": "Fat in type 2 becomes dark on fat-suppressed T2/STIR, so a low signal on those sequences is not sufficient for type 3. Type 3 requires low signal on conventional T1 and non-fat-suppressed T2 plus a sclerotic correlate when available.",
"CT_radiograph_role": "CT or radiographs may corroborate sclerosis in type 3 but cannot independently assign the MRI signal classification.",
"comparison_rule": "Serial comparison should use technically comparable sequences; otherwise qualify apparent change in type or extent as technically limited."
},
"category_algorithm": [
{
"step": 1,
"pattern": "low_T1_and_high_non_fat_suppressed_T2_adjacent_to_degenerative_endplate",
"output": "1"
},
{
"step": 2,
"pattern": "high_T1_and_iso_to_slightly_high_non_fat_suppressed_T2",
"output": "2"
},
{
"step": 3,
"pattern": "low_T1_and_low_non_fat_suppressed_T2_with_sclerotic_morphology",
"output": "3"
},
{
"step": 4,
"pattern": "more_than_one_pattern_within_the_same_level_or_endplate",
"output": "mixed_type_with_each_component_retained"
},
{
"step": 5,
"pattern": "signal_does_not_match_or_required_sequences_are_missing",
"output": "indeterminate_or_non_Modic_differential"
}
],
"type_and_mixed_pattern_rules": {
"type_1": "Low T1/high T2 reflects a water-rich fibrovascular endplate phenotype. The colloquial word active must not be converted into proof of painful inflammation or infection.",
"type_2": "High T1 with iso/slightly high T2 reflects fatty marrow replacement; use the T1 fat signal and non-fat-suppressed sequence context to avoid misclassification.",
"type_3": "Low T1/low T2 reflects sclerosis and was detailed in the companion 1988 imaging paper. It is less common and should not be assigned from low STIR signal alone.",
"mixed_patterns": "Mixed I/II and II/III patterns occur. Report both components and their spatial distribution; do not force the dominant area into a pure type or create an unsupported arithmetic score.",
"nonordinal_rule": "Types are tissue-signal phenotypes, not three validated steps of symptom severity, treatment urgency or inevitable temporal progression."
},
"minimum_structured_report": {
"anatomy": [
"disc_level",
"cranial_endplate",
"caudal_endplate",
"laterality_or_centrality",
"anterior_middle_posterior_distribution"
],
"phenotype": [
"pure_or_mixed_type",
"component_types",
"qualitative_or_contoured_extent",
"dominant_component_only_if_explicitly_labeled"
],
"companions": [
"disc_degeneration_and_height",
"endplate_defect_or_Schmorl_node",
"erosion_or_destruction",
"sclerosis",
"enhancement_if_contrast_given",
"paraspinal_or_epidural_abnormality",
"comparison_change"
],
"reproducibility_context": [
"field_strength",
"T1_parameters",
"T2_parameters",
"fat_suppression",
"slice_thickness_and_orientation"
]
},
"type_1_differential_and_safety_gate": {
"mimics": [
"infectious_spondylodiscitis",
"acute_Schmorl_node",
"acute_or_subacute_fracture",
"inflammatory_spondyloarthropathy",
"tumor_or_treatment_related_marrow_change"
],
"infection_supporting_features": [
"progressive_endplate_erosion_or_destruction",
"fluid_like_or_markedly_high_disc_T2_signal",
"disc_and_endplate_enhancement_in_context",
"paraspinal_or_epidural_phlegmon_or_abscess",
"systemic_or_laboratory_evidence_of_infection"
],
"enhancement_boundary": "Endplate and disc enhancement can occur with degeneration and infection; enhancement alone does not settle the diagnosis.",
"diffusion_claw": "On appropriate DWI, a paired well-marginated linear claw at the normal-abnormal marrow interface supports degeneration, while diffuse amorphous DWI signal raises infection concern. This is supportive evidence from a retrospective cohort, not part of the original Modic category or an absolute exclusion test.",
"action_rule": "If infection, fracture or tumor is plausible, surface that differential and recommend context-appropriate diagnostic escalation independently of the Modic label; never reassure from type 1 alone."
},
"symptoms_risk_and_management_context": {
"pain_association": "A 2018 systematic review of 31 studies found inconsistent associations between Modic change and low-back-pain or activity-limitation outcomes, with substantial heterogeneity and high risk of bias.",
"pain_generator_rule": "No Modic type proves that the indexed level generates pain, and absence of Modic change does not exclude clinically important discogenic or other spinal pain.",
"prognosis_rule": "Type and longitudinal conversion do not provide a calibrated individual forecast of pain, disability, degeneration rate, fracture, cancer or surgical outcome.",
"treatment_rule": "The classification does not choose observation, physical therapy, injection, surgery, ablation or medication. Integrate symptoms, examination, other imaging findings, duration, prior care and patient goals.",
"antibiotic_evidence": "The 2019 AIM randomized trial found no clinically important one-year benefit from three months of amoxicillin in its selected chronic-low-back-pain population. A 2026 Cochrane review found only low-certainty slight-to-small short-term pain benefit and small-to-moderate disability benefit in selected patients with type 1 change plus disc herniation, with very uncertain harms; a Modic image is therefore not a standalone antibiotic indication.",
"stewardship_rule": "Do not recommend or prescribe antibiotics from the type alone. Suspected spinal infection follows an infection workup; experimental or selected chronic-pain antibiotic evidence requires specialist clinical judgment and antimicrobial stewardship."
},
"longitudinal_rules": {
"preserve_trajectory": "Record prior and current component types and extents at each level; mixed change can evolve in more than one direction and should not be reduced to a presumed fixed sequence 1-to-2-to-3.",
"technical_change": "Before calling conversion or enlargement, check sequence comparability and fat suppression.",
"clinical_change": "New fever, bacteremia risk, severe rest/night pain, neurologic deficit or rapidly destructive morphology overrides a routine degenerative follow-up interpretation."
},
"agent_output_contract": [
"each_disc_level_and_each_adjacent_endplate",
"pure_mixed_or_indeterminate_Modic_phenotype",
"T1_and_non_fat_suppressed_T2_signal_evidence",
"spatial_extent_and_distribution",
"sequence_and_comparison_adequacy",
"disc_endplate_paraspinal_epidural_and_sclerotic_companions",
"infection_fracture_inflammatory_and_tumor_differential_when_relevant",
"no_pain_generator_prognosis_or_treatment_inference_from_type_alone"
],
"missing_input_behavior": [
"If conventional T1 is unavailable, do not assign type 1 versus type 2 from fluid-sensitive imaging alone.",
"If only fat-suppressed T2/STIR is available, do not assign type 2 versus type 3 from low signal; return sequence-limited.",
"If two tissue patterns coexist, return a mixed type and map each component instead of selecting one code.",
"If destructive endplate, disc, paraspinal or systemic features raise infection, return Modic-versus-infection uncertainty and prioritize the safety differential.",
"If symptoms and examination are absent, report morphology only and withhold pain causality and management conclusions."
],
"supporting_sources": [
{
"role": "primary_types_1_and_2",
"citation": "Modic et al. Radiology. 1988;166:193-199",
"doi": "10.1148/radiology.166.1.3336678",
"pmid": "3336678"
},
{
"role": "type_3_and_imaging_context",
"citation": "Modic et al. Radiology. 1988;168:177-186",
"doi": "10.1148/radiology.168.1.3289089",
"pmid": "3289089"
},
{
"role": "reporting_recommendations",
"citation": "Fields et al. Eur Spine J. 2019;28:2266-2274",
"doi": "10.1007/s00586-019-06119-6",
"pmcid": "PMC7205555"
},
{
"role": "pain_association_limit",
"citation": "Herlin et al. PLoS One. 2018;13:e0200677",
"doi": "10.1371/journal.pone.0200677",
"pmcid": "PMC6070210"
},
{
"role": "infection_differential",
"citation": "Patel et al. AJNR. 2014;35:1647-1652",
"doi": "10.3174/ajnr.A3948",
"pmcid": "PMC7964436"
},
{
"role": "antibiotic_randomized_trial",
"citation": "Bråten et al. BMJ. 2019;367:l5654",
"doi": "10.1136/bmj.l5654",
"pmcid": "PMC6812614"
},
{
"role": "current_antibiotic_synthesis",
"citation": "Liu et al. Cochrane Database Syst Rev. 2026;4:CD014221",
"doi": "10.1002/14651858.CD014221.pub2",
"pmid": "41944232"
}
],
"source_locator": "Modic et al. 1988, DOI 10.1148/radiology.166.1.3336678, abstract and histologic correlation for types 1-2; Modic et al. 1988, DOI 10.1148/radiology.168.1.3289089 for type 3; Fields et al. 2019, PMC7205555, Recommendations and Tables for acquisition, measurement, mixed types and reporting; Herlin et al. 2018, PMC6070210, Results/Conclusions for inconsistent pain associations; Patel et al. 2014, PMC7964436, Methods/Results for the DWI claw sign; Bråten et al. 2019, PMC6812614, Results/Conclusions; Liu et al. 2026 Cochrane review, DOI 10.1002/14651858.CD014221.pub2, Authors' conclusions."
}Categorias num relance
| Cat. | Significado | Conduta | Risco | Fonte |
|---|---|---|---|---|
| 1 | Type 1, edematous or inflammatory At a named disc/endplate level, marrow immediately adjacent to the endplate is low signal on conventional T1-weighted MRI and high signal on conventional non-fat-suppressed T2-weighted MRI relative to normal vertebral marrow. The tissue correlate is endplate disruption/fissuring with water-rich fibrovascular marrow replacement; map cranial/caudal endplate, distribution, extent and any mixed type 2 component. | Report a type 1 or mixed 1/2 phenotype with sequence adequacy and actively check for infection, acute Schmorl node, fracture, inflammatory disease and tumor when morphology or clinical context warrants. The Modic label does not select analgesia, rehabilitation, injection, surgery or antibiotics; suspected infection follows its own urgent diagnostic pathway. | Type 1 is an edematous/fibrovascular imaging phenotype, not proof of painful inflammation or occult infection. Pain associations across studies are inconsistent. The 2019 AIM trial found no clinically important one-year amoxicillin benefit, while a 2026 Cochrane synthesis found only low-certainty small short-term benefits in selected type-1-plus-disc-herniation patients and very uncertain harms; neither supports image-only prescribing. | okfonte Modic et al. 1988, DOI 10.1148/radiology.166.1.3336678, abstract/results for low T1/high T2 and fibrovascular tissue; Fields et al. 2019, PMC7205555, reporting recommendations; Herlin et al. 2018, PMC6070210, Results/Conclusions; Bråten et al. 2019, PMC6812614, primary outcome; Liu et al. 2026, DOI 10.1002/14651858.CD014221.pub2, Authors' conclusions. |
| 2 | Type 2, fatty Endplate-adjacent marrow is high signal on conventional T1-weighted MRI and isointense to slightly high signal on conventional non-fat-suppressed T2-weighted MRI, corresponding to fatty yellow-marrow replacement. Fat suppression can make the same tissue dark on fluid-sensitive imaging, so retain the actual sequence context and any mixed type 1 or type 3 component. | Describe the level, both adjacent endplates, extent and mixed pattern, with disc degeneration and endplate defects reported separately. Type 2 does not identify the symptomatic level or dictate conservative care, procedure or surgery; management requires clinical concordance and the complete spine examination. | Type 2 is a fatty degenerative marrow phenotype, not a calibrated stage of pain, disability or future deterioration. It can persist, coexist with type 1 or type 3, or change over time, and it neither excludes another pain generator nor supplies a treatment-response probability. | okfonte Modic et al. 1988, DOI 10.1148/radiology.166.1.3336678, abstract/results for high T1, iso/slightly high T2 and fatty replacement; Fields et al. 2019, PMC7205555, sections on sequence effects, mixed phenotypes, measurement and reporting; Herlin et al. 2018, PMC6070210, association limitations. |
| 3 | Type 3, sclerotic Endplate-adjacent marrow is low signal on both conventional T1-weighted and conventional non-fat-suppressed T2-weighted MRI, corresponding to subchondral sclerosis. Corroborating dense sclerosis on CT or radiographs supports the interpretation; low signal only on fat-suppressed T2/STIR is insufficient because fat is also suppressed there. | Report type 3 at the exact level with extent, endplate morphology and any mixed type 2 component. CT or radiographs may clarify sclerosis, but the type itself does not require intervention or identify a pain generator; address fracture, destructive lesion or other competing diagnosis on its own evidence. | Type 3 is an uncommon sclerotic phenotype, not a validated end-stage prognosis and not evidence that symptoms are irreversible. A pure or mixed type 3 category does not predict pain severity, fracture, cancer, progression rate or benefit from surgery. | okfonte Modic et al. 1988, Imaging of degenerative disk disease, DOI 10.1148/radiology.168.1.3289089, type 3 low-T1/low-T2 sclerotic pattern; Fields et al. 2019, PMC7205555, sequence/reporting recommendations and mixed phenotypes. |
Referências cruzadas
Histórico de versões
| Data | Evento | Detalhe | Situação |
|---|---|---|---|
| 2026-08-01 | revised | Monitored source changed (version_regex). Detected automatically; awaiting reviewer confirmation. evidência | aguardando revisão |
| 2026-07-24 | revised | Monitored source changed (content_hash). Detected automatically; awaiting reviewer confirmation. evidência | descartado |
| 1988-07-01 | revised | The companion imaging paper described the low-T1 and low-T2 sclerotic type 3 phenotype, completing the commonly used three-type map. | confirmado |
| 1988-01-01 | published | Modic and colleagues published the original type 1 and type 2 vertebral endplate marrow signal phenotypes. | confirmado |
curl -s "https://radcommons.laudos.ai/api/v1/systems/modic"Ver documentação completa